Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of immunosuppressives in immunosenescence and immunotolerance in renal transplantation
2011-003604-21Phase 4Completed
- Sponsor
- Department of Internal Medicine IV, Medical University of Innsbruck
- Start
- Sep 2011
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of everolimus, sirolimus, ciclosporin and tacrolimus in kidney transplant (2 arms), sponsored by Department of Internal Medicine IV, Medical University of Innsbruck. Primary endpoint: Immunological parameters. Started Sep 2011; status: completed.
02
Drugs
everolimussirolimusciclosporintacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2011-003604-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003604-21.